🇩🇰 Short selling in Denmark, Q3 2023

From 3 Jul 2023 to 29 Sep 2023, 50 Denmark companies carried disclosed short positions. The quarter's highest single reading was Novozymes A/S at 10.77% on 29 Sep 2023. 1 left it. Figures are disclosed positions from official Danish FSA data.

← Q2 2023 Q4 2023 →

Cite this page

Plain

Short position data for Short selling in Denmark, Q3 2023: Danish FSA, compiled by howshorted.com, position date 29 Sep 2023. https://howshorted.com/dk/review/2023-q3/

Wikipedia

<ref>{{cite web |title=Short selling in Denmark, Q3 2023 short position data |url=https://howshorted.com/dk/review/2023-q3/ |website=HowShorted |publisher=howshorted.com (data: Danish FSA) |date=2023-09-29 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-short-selling-in-denmark-q3-2023-2023-09-29,
  title        = {Short selling in Denmark, Q3 2023 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/dk/review/2023-q3/}},
  note         = {Data: Danish FSA, position date 29 Sep 2023; accessed 2026-10-13},
  year         = {2023}
}

Biggest rises of the quarter

ChemoMetec A/S+3.32pp to 6.78%
Bavarian Nordic A/S+3.07pp to 8.83%
Novozymes A/S+2.45pp to 10.77%
GN Store Nord A/S+2.40pp to 5.79%
ISS A/S+1.70pp to 3.94%

Biggest falls of the quarter

Pandora A/S−2.91pp to 1.56%
NKT A/S−2.17pp to 1.29%
Noble Corporation Plc−1.52pp to 1.95%
Chr. Hansen Holding A/S−0.68pp to 0.40%
Zealand Pharma A/S−0.41pp to 3.56%

Changes compare each company's last figure of the quarter with its first; companies with a single publication day in the quarter are counted but not ranked. Where disclosure thresholds apply the figures are floors, not a census. Nothing here is investment advice.